Holen Sie sich die Stockscreener-App
0.921
0.83%
-0.0077
Handel nachbörslich:
.94
0.019
+2.06%
Schlusskurs vom Vortag:
$0.9287
Offen:
$0.9477
24-Stunden-Volumen:
39,532
Relative Volume:
0.26
Marktkapitalisierung:
$13.94M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-7.78M
KGV:
-0.8902
EPS:
-1.0346
Netto-Cashflow:
$-7.49M
1W Leistung:
+0.10%
1M Leistung:
-12.29%
6M Leistung:
-21.28%
1J Leistung:
-33.98%
1-Tages-Spanne:
$0.9119
$0.9499
1-Wochen-Bereich:
$0.881
$1.07
52-Wochen-Spanne:
$0.75
$1.80
Biocardia Inc Stock (BCDA) Company Profile
Firmenname
Biocardia Inc
Sektor
Branche
Telefon
650-226-0123
Adresse
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA vs VRTX, REGN, MRNA, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BCDA
Biocardia Inc
|
0.921 | 13.94M | 3,000 | -7.78M | -7.49M | -1.0346 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-16 | Herabstufung | Dawson James | Buy → Neutral |
Biocardia Inc Aktie (BCDA) Neueste Nachrichten
Form 4 Biocardia Inc: Peter Altman (Director, President and CEO) For: 15 October - Investing.com UK
At $0.95 per share, BioCardia (BCDA) CEO buys 500 shares across two purchases. - Stock Titan
FDA Accepts BioCardia's De Novo Pre-Submission for Helix Catheter, Review Scheduled This Quarter - Kalkine Media
BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting - GlobeNewswire Inc.
BioCardia president and CEO Peter Altman buys $1,030 in shares - Investing.com
At $1.03 a share, BioCardia (BCDA) CEO Peter Altman buys 1,000 shares. - Stock Titan
BioCardia CEO Peter Altman buys $1,995 in stock By Investing.com - Investing.com Canada
BioCardia CEO Peter Altman buys $1,995 in stock - Investing.com
BioCardia (BCDA) CEO buys shares at an average $1.05 each, bringing his direct holdings to 383,885. - Stock Titan
BioCardia Shares Fall 10% After Hours: Here's Why - Benzinga
BioCardia Shares Fall 10% After Hours: Here's Why - Benzinga
BioCardia Shares Fall 10% After Hours: Here's Why - TradingView
BioCardia Shares Fall 10% After Hours: Here's Why - Webull
BioCardia regains Nasdaq minimum $1.00 bid-price compliance, listing matter closed - TradingView
Form 8K Biocardia Inc For: 10 September By Investing.com - Investing.com Canada
Form 8K Biocardia Inc For: 10 September By Investing.com - Investing.com India
Form 8K Biocardia Inc For: 10 September By Investing.com - Investing.com UK
BioCardia to Present CardiAMP, Helix and Heart3D Progress at H.C. Wainwright Global Investment Conference - Quiver Quantitative
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
BioCardia to present CardiAMP regulatory progress, Helix and Heart3D updates at H.C. Wainwright - TradingView
A heart-failure cell therapy could reach Japanese regulators by year-end. BioCardia is preparing the filing. - Stock Titan
Form 8K Biocardia Inc For: 10 September By Investing.com - Investing.com Nigeria
BioCardia CEO Peter Altman buys 800 shares for $872 - Bitget
BioCardia CEO Peter Altman buys $872 in company stock By Investing.com - Investing.com Nigeria
BioCardia CEO Peter Altman buys $872 in company stock - Investing.com
BioCardia CEO Peter Altman buys $872 in company stock By Investing.com - Investing.com South Africa
BioCardia CEO Peter Altman buys $872 in company stock - Investing.com
BioCardia (BCDA) CEO adds 800 shares in open-market buy - Stock Titan
BioCardia Inc. Warrant (BCDAW) Key Financial Ratios – Valuation, Profitability & More - Value Research
BioCardia (BCDA) Session: Finishes 4.95% Higher at $1.06 at the Close; Price Setup: Price Remains Between $1.01 Support and $1.11 Resistance on the DaySmart Beta Flow - vinanet.vn
BioCardia receives FDA confirmation on Helix catheter meeting By Investing.com - Investing.com Nigeria
BioCardia Advances Helix Catheter Toward De Novo Approval - TipRanks
BioCardia receives FDA confirmation on Helix catheter meeting By Investing.com - Investing.com India
BioCardia (BCDA) Session: Finishes 4.95% Higher at $1.06 at the Close; Price Setup: Price Remains Between $1.01 Support and $1.11 Resistance on the DayDonchian Channel - dars.gov.et
BioCardia Receives Nasdaq Notice on Minimum Bid Price - The Globe and Mail
BioCardia Received Notice of Noncompliance - TradingView
BioCardia’s Q2 2026 Update Keeps the Regulatory Story Alive, but Capital Still Drives the Risk - AlphaStreet
BioCardia CEO Peter Altman acquires 5,400 common shares worth $5,022 - Bitget
BioCardia CEO Peter Altman buys $5,022 in company stock - Investing.com
BioCardia CEO Peter Altman buys $5,022 in company stock - Investing.com
BioCardia (BCDA) CEO buys 5,400 shares in open market - Stock Titan
BCDA Q2 2026 Earnings: EPS Surprise of 29.19% Narrows Losses as Shares Climb 4.82%Estimate Revision Count - vinanet.vn
BioCardia (BCDA) Pushes Higher: Micro-Cap Biotech Gains 4.8% as It Nears $1.02 ResistanceIceberg Order - vinanet.vn
BioCardia (BCDA) Pushes Higher: Micro-Cap Biotech Gains 4.8% as It Nears $1.02 ResistanceValue Area High - dars.gov.et
BCDA Q2 2026 Earnings: Narrower-than-Expected Loss Drives Shares Up 4.82%Earnings Revision Upgrade - vinanet.vn
Why Did BCDA Stock Surge More Than 50% Today? - Stocktwits
BioCardia CEO Peter Altman buys $1,748 in company stock By Investing.com - Investing.com Canada
BioCardia CEO Peter Altman buys $1,748 in company stock - Investing.com
BioCardia CEO Peter Altman buys $1,748 in company stock By Investing.com - Investing.com India
BioCardia CEO Peter Altman buys $1,748 in company stock By Investing.com - Investing.com UK
Finanzdaten der Biocardia Inc-Aktie (BCDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biocardia Inc-Aktie (BCDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Altman Peter | President and CEO |
Oct 15 '26 |
Buy |
0.95 |
200 |
190 |
385,085 |
| Altman Peter | President and CEO |
Sep 29 '26 |
Buy |
1.03 |
1,000 |
1,030 |
384,885 |
| Altman Peter | President and CEO |
Sep 23 '26 |
Buy |
1.05 |
1,900 |
1,995 |
383,885 |
| Altman Peter | President and CEO |
Sep 03 '26 |
Buy |
1.09 |
800 |
872 |
381,985 |
| Altman Peter | President and CEO |
Aug 17 '26 |
Buy |
0.93 |
5,400 |
5,022 |
381,115 |
| Altman Peter | President and CEO |
Aug 13 '26 |
Buy |
0.92 |
1,900 |
1,748 |
375,785 |
| Altman Peter | President and CEO |
Jul 29 '26 |
Buy |
0.78 |
5,000 |
3,900 |
373,885 |
| Altman Peter | President and CEO |
Jul 17 '26 |
Buy |
0.83 |
500 |
415 |
368,885 |
| Altman Peter | President and CEO |
Jul 15 '26 |
Buy |
0.86 |
1,500 |
1,290 |
368,385 |
| Altman Peter | President and CEO |
Jul 14 '26 |
Buy |
0.88 |
2,800 |
2,464 |
366,885 |
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):